• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病中呼吸困难的机制与测量

Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease.

作者信息

Mahler Donald A

机构信息

Dartmouth Medical School, Lebanon, NH 03756-0001, USA.

出版信息

Proc Am Thorac Soc. 2006 May;3(3):234-8. doi: 10.1513/pats.200509-103SF.

DOI:10.1513/pats.200509-103SF
PMID:16636091
Abstract

Patients with chronic obstructive pulmonary disease (COPD) describe their breathlessness as related to the work and effort associated with breathing. Current evidence suggests that the perception of dyspnea is due to a "mismatch" between the outgoing motor command from the central nervous system and the corresponding afferent information from chemoreceptors and/or mechanoreceptors. To measure the severity of dyspnea the principles of psychophysics (stimulus --> response relationship) can be applied. One approach is to consider activities of daily living as a putative stimulus. Although this method relies on patient recall and description of daily tasks, ability to function, as well as time and effort to complete an activity, select clinical instruments have demonstrated appropriate measurement criteria in randomized clinical trials involving patients with COPD. Another approach is for a patient to report the intensity of dyspnea during exercise, and current practice is to provide ratings each minute "on cue" during the exercise test. A computerized system has been developed whereby the person can report ratings spontaneously and continuously by moving a computer mouse that adjusts a vertical bar adjacent to 0-10 category-ratio scale positioned on a monitor. With this continuous method the patient reports twice the number of dyspnea ratings during exercise compared with discrete ratings each minute. Patient-reported dyspnea based on activities of daily living and exercise testing provides distinct but complimentary information.

摘要

慢性阻塞性肺疾病(COPD)患者称其呼吸困难与呼吸相关的工作和努力有关。目前的证据表明,呼吸困难的感知是由于中枢神经系统发出的传出运动指令与来自化学感受器和/或机械感受器的相应传入信息之间存在“不匹配”。为了测量呼吸困难的严重程度,可以应用心理物理学原理(刺激→反应关系)。一种方法是将日常生活活动视为一种假定的刺激。尽管这种方法依赖于患者对日常任务的回忆和描述、功能能力以及完成一项活动所需的时间和精力,但在涉及COPD患者的随机临床试验中,某些临床工具已显示出适当的测量标准。另一种方法是让患者报告运动期间呼吸困难的强度,目前的做法是在运动测试期间每分钟“按提示”提供评分。已经开发出一种计算机化系统,通过移动计算机鼠标来调整与显示器上0至10类别比例量表相邻的垂直条,患者可以自发且连续地报告评分。采用这种连续评分方法,患者在运动期间报告的呼吸困难评分数量是每分钟离散评分的两倍。基于日常生活活动和运动测试的患者报告的呼吸困难提供了不同但互补的信息。

相似文献

1
Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中呼吸困难的机制与测量
Proc Am Thorac Soc. 2006 May;3(3):234-8. doi: 10.1513/pats.200509-103SF.
2
Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.GOLD 1期慢性阻塞性肺疾病有症状患者在周期性运动期间呼吸困难的机制
Am J Respir Crit Care Med. 2008 Mar 15;177(6):622-9. doi: 10.1164/rccm.200707-1064OC. Epub 2007 Nov 15.
3
Pathophysiology of exercise dyspnea in healthy subjects and in patients with chronic obstructive pulmonary disease (COPD).健康受试者及慢性阻塞性肺疾病(COPD)患者运动性呼吸困难的病理生理学
Respir Med. 2005 Nov;99(11):1403-12. doi: 10.1016/j.rmed.2005.03.005. Epub 2005 Apr 26.
4
Perception of breathlessness during exercise in patients with respiratory disease.呼吸系统疾病患者运动时呼吸困难的感知
Med Sci Sports Exerc. 1994 Sep;26(9):1078-81.
5
Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD.慢性阻塞性肺疾病(COPD)男性患者日常生活活动时的呼吸困难与运动时的最大呼吸困难对比
Respir Med. 2006 Jun;100(6):965-71. doi: 10.1016/j.rmed.2005.10.006. Epub 2005 Nov 18.
6
Clinical utility of measures of breathlessness.呼吸急促测量的临床效用。
Respir Care. 2002 Sep;47(9):986-93.
7
Activation of the prefrontal cortex is associated with exertional dyspnea in chronic obstructive pulmonary disease.前额叶皮层的激活与慢性阻塞性肺疾病的运动性呼吸困难有关。
Respiration. 2011;82(6):492-500. doi: 10.1159/000324571. Epub 2011 Apr 7.
8
Stability of dyspnea ratings after exercise training in patients with COPD.慢性阻塞性肺疾病患者运动训练后呼吸困难评分的稳定性
Med Sci Sports Exerc. 2003 Jul;35(7):1083-7. doi: 10.1249/01.MSS.0000074456.10983.CF.
9
Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance.肥胖与慢性阻塞性肺疾病对呼吸困难和运动耐量的联合影响。
Am J Respir Crit Care Med. 2009 Nov 15;180(10):964-71. doi: 10.1164/rccm.200904-0530OC.
10
[Cardiac autonomic responses to exercise testing in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者运动试验中的心脏自主神经反应]
Anadolu Kardiyol Derg. 2010 Apr;10(2):104-10. doi: 10.5152/akd.2010.032.

引用本文的文献

1
Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow.未达最佳峰吸气流速的慢性阻塞性肺疾病患者的临床负担。
Can Respir J. 2024 Mar 22;2024:8034923. doi: 10.1155/2024/8034923. eCollection 2024.
2
An Initial Assessment of the Decline With Age for the 6-minute Walk Test (6MWT) in Chinese Older Adults With Chronic Obstructive Pulmonary Disease (COPD).对中国慢性阻塞性肺疾病(COPD)老年患者6分钟步行试验(6MWT)随年龄下降情况的初步评估。
Arch Rehabil Res Clin Transl. 2023 Feb 26;5(2):100262. doi: 10.1016/j.arrct.2023.100262. eCollection 2023 Jun.
3
Adiposity increases weight-bearing exercise-induced dyspnea despite favoring resting lung hyperinflation in COPD.
肥胖增加了与承重运动相关的呼吸困难,尽管它有利于 COPD 患者静息时肺部过度充气。
Chron Respir Dis. 2022 Jan-Dec;19:14799731211052305. doi: 10.1177/14799731211052305.
4
Gender Differences in Chronic Obstructive Pulmonary Disease Symptom Clusters.性别差异与慢性阻塞性肺疾病症状群。
Int J Chron Obstruct Pulmon Dis. 2021 Apr 20;16:1101-1107. doi: 10.2147/COPD.S302877. eCollection 2021.
5
The Manchester Respiratory Activities of Daily Living Questionnaire: Reliability and Validity of the Chinese Version with Pictorial Enhancement.《曼彻斯特日常活动呼吸问卷中文版:带有图像增强的信度和效度》。
Int J Chron Obstruct Pulmon Dis. 2021 Jan 15;16:91-100. doi: 10.2147/COPD.S283769. eCollection 2021.
6
Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.噻托溴铵和奥达特罗对 COPD 患者症状和患者报告结局的影响:四项随机、双盲研究的结果。
NPJ Prim Care Respir Med. 2017 Feb 2;27(1):7. doi: 10.1038/s41533-016-0002-x.
7
Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.在GOLD 2-4级慢性阻塞性肺疾病(COPD)患者中,与安慰剂及每日两次使用福莫特罗相比,通过Respimat®每日一次给药奥达特罗的肺功能疗效及症状改善情况:两项重复的48周研究结果
Int J Chron Obstruct Pulmon Dis. 2014 Jul 5;9:697-714. doi: 10.2147/COPD.S62502. eCollection 2014.
8
Chronic obstructive pulmonary disease in China: the potential role of indacaterol.中国的慢性阻塞性肺疾病:茚达特罗的潜在作用。
J Thorac Dis. 2013 Aug;5(4):549-58. doi: 10.3978/j.issn.2072-1439.2013.08.04.
9
The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea.吗啡治疗慢性难治性呼吸困难时的纵向反应模式。
J Palliat Med. 2013 Aug;16(8):881-6. doi: 10.1089/jpm.2012.0591. Epub 2013 Jun 8.
10
Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study.呼吸困难严重程度、呼吸困难状态变化与一般人群死亡率:弗拉格韦德/弗拉尔丁恩研究。
Eur J Epidemiol. 2012 Nov;27(11):867-76. doi: 10.1007/s10654-012-9736-0. Epub 2012 Oct 7.